Drug-Resistant Epilepsy: Current Challenges and Solutions

Drug-resistant epilepsy remains a significant challenge in the field, with a substantial proportion of patients not achieving adequate seizure control with available antiepileptic medications. This session will explore the underlying factors contributing to drug resistance, including genetic, pharmacokinetic, and pharmacodynamic considerations. Understanding these mechanisms is crucial for developing new therapeutic strategies and optimizing treatment regimens for drug-resistant epilepsy.
Recent research is focused on identifying novel drug targets and developing innovative treatment approaches, such as personalized medicine and drug delivery systems. Advances in genetic and molecular research are providing insights into potential therapeutic targets and mechanisms of drug resistance. By addressing these challenges and exploring new solutions, the goal is to improve seizure control and quality of life for individuals with drug-resistant epilepsy.

    Related Conference of Drug-Resistant Epilepsy: Current Challenges and Solutions

    July 27-28, 2026

    55th World Congress on Microbiology

    Paris, France
    August 27-28, 2026

    13th World Summit on Epilepsy and Bipolar Disorders

    Paris, France
    August 27-28, 2026

    14th World Congress and Expo on Applied Microbiology

    Barcelona, Spain

    Drug-Resistant Epilepsy: Current Challenges and Solutions Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in